Is 1H NMR metabolomics becoming the promising early biomarker for neonatal sepsis and for monitoring the antibiotic toxicity?

Antonio Noto, Michele Mussap, Vassilios Fanos

Research output: Contribution to journalArticle

Abstract

Metabolomics, the latest of omics disciplines, has been successfully used in various fields of basic research such as pharmacology and toxicology. Recently, this new science has gained an important role in the translational research of diagnostics. In this regard, the challenge for neonatologists and medical laboratories is to diagnose neonatal sepsis, a disease with high mortality and morbidity due to the difficulty in diagnosing it. Metabolomics, through its ability to identify perturbations caused by this condition, aims at recognizing metabolites that characterize neonatal sepsis with high specificity and sensitivity. The purpose of this review is to highlight the ability of metabolomics to find early biomarkers for this condition, as well as to predict the toxic effects caused by antibiotics.

Original languageEnglish
Pages (from-to)130-132
Number of pages3
JournalJournal of Chemotherapy
Volume26
Issue number3
DOIs
Publication statusPublished - 2014

Keywords

  • Aminoglycosides
  • Antibiotics
  • Metabolomics
  • Neonatal sepsis
  • Renal toxicity

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Infectious Diseases
  • Oncology
  • Pharmacology
  • Medicine(all)

Fingerprint Dive into the research topics of 'Is 1H NMR metabolomics becoming the promising early biomarker for neonatal sepsis and for monitoring the antibiotic toxicity?'. Together they form a unique fingerprint.

  • Cite this